Vincorion’s €149M Order Haul and EU Grant Fail to Quell Lock-Up Fears

Vincorion's stock drops 20% from high despite record Q1 orders and €1.2B backlog; analysts see 34% upside but lock-up expiry in autumn 2026 poses risk.

A curious disconnect is playing out in Vincorion’s stock. The defence supplier booked a record €149.4 million in new orders during the first quarter of 2026 – nearly four times the prior-year level – pushing its total backlog to roughly €1.2 billion. Yet the shares closed at €18.18 on Friday, down 3.5% on the day and almost 20% below the all-time high of €22.58 touched in early May. With a relative strength index of 22, the equity is now deeply oversold by any technical measure.

The sell-off has little to do with operations. Management reaffirmed its full-year guidance on Thursday, targeting group revenue between €280 million and €320 million and an adjusted EBIT margin of 18% to 19%. Medium-term ambitions are even bolder: annual top-line growth of more than 15% and margins of around 20%. More than 90% of this year’s planned sales are already covered by firm orders, giving the company unusual visibility.

Vincorion is also pushing ahead with a self-funded expansion of its three production sites in Altenstadt, Essen and Wedel. New pulse lines are being installed to boost throughput, and logistics are being streamlined – all financed from current cash flow. The group expects to generate roughly €38 million in operating cash flow in 2026. No capital increases or fresh debt are planned, according to management. The workforce, which currently stands at about 900 employees, is set to grow by 5% to 6% annually.

Alongside the factory upgrades, Vincorion is participating in the SENTINEL research project, backed by €39.9 million from the European Defence Fund. The initiative involves 42 partners from 16 countries and aims to develop mobile field camps independent of external infrastructure. Vincorion is contributing a 50-kilowatt generator module and an equally powerful energy storage module. Initial tests are already underway with the University of the Bundeswehr in Munich, with further trials scheduled in the Netherlands and on Aruba.

Analysts remain bullish despite the share price weakness. Berenberg rates the stock a “Buy” with a €26 price target, while JPMorgan sees fair value at €23.50. The consensus average stands at €25, implying roughly 34% upside from current levels. A board member added to his stake in mid-May, a clear insider vote of confidence that the annual targets are achievable. The Greenshoe option has now expired, lifting the free float to around 52.5% and improving liquidity for institutional investors.

Berenberg also highlights a supportive macro backdrop: Germany’s defence budget could expand at a compound rate of 20% per year to roughly €157 billion by 2030, and Vincorion generates 60% of its revenue domestically. That structural tailwind, however, is tempered by a looming overhang. Principal shareholder STAR Capital holds 47.5% of the shares and is bound by a lock-up agreement that expires in autumn 2026. When that restriction lifts, a large block of stock could hit a market that already looks thin. The market capitalisation has shrunk to around €910 million from roughly €1.1 billion at the May peak, making the potential supply even more weighty.

For now, the chart offers a technical floor near €18. If that support holds, a bounce towards €20 is plausible in the near term. The real test, though, will come on 12 August when Vincorion publishes its half-year results. Investors will be watching closely to see whether the post-expansion cash flow is firming up and whether the operating margin is tracking towards the upper end of the guided range – both arguments that could help offset the lock-up risk when STAR Capital’s restriction eventually lifts.